Katy Rezvani
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Katy Rezvani
Apr 17, 2024, 00:49 |
Blog
Hind Rafei: Tour de force presentation today by Dr. Katy Rezvani at the Allison Institute
Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Mar 29, 2024, 05:47 |
Blog
Nitin Jain: Fantastic talk by Dr Hind Rafei on current status of NK cell therapy
Katy Rezvani Chief of Section of Cellular Therapy, Department of Stem Cell Transplantation and Cellular…
Mar 13, 2024, 09:23 |
Blog
Katy Rezvani: Important study showing the promise of locoregional delivery of CAR-T cells in glioblastoma
Katy Rezvani, Chief, Section of Cellular Therapy at the Department of Stem Cell Transplantation and…
Feb 4, 2024, 18:10 |
Insight
Giulio Draetta: These results reflect the vision, passion and determination of Katy Rezvani and her MD Anderson team
Giulio Draetta, Chief Scientific Officer at The University of Texas M.D. Anderson Cancer Center, shared…
Jan 24, 2024, 17:02 |
Blog
May Daher: Not all donors are created equal!
May Daher, Physician scientist at MD Anderson Cancer Center, shared a post by Saheli Sadanand,…
Jan 21, 2024, 18:52 |
Insight
Katy Rezvani: Our paper on our Phase I / II trial with cord blood CAR19/IL15 NK cells is published
Katy Rezvani, Chief of Section of Cellular Therapy, Department of Stem Cell Transplantation and Cellular…
Dec 9, 2023, 16:41 |
Blog
Congratulations to our Dr. Katy Rezvani on receiving the 2023 E. Donnall Thomas Lecture and Prize by The American Society of Haematology - MD Anderson Cancer Centre
Katy Rezvani, Chief of Section of Cellular Therapy, Department of Stem Cell Transplantation and Cellular…
All:
8
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube